Lawson, Keith A.
Sousa, Cristovão M.
Zhang, Xiaoyu
Kim, Eiru http://orcid.org/0000-0002-1901-5670
Akthar, Rummy
Caumanns, Joseph J.
Yao, Yuxi
Mikolajewicz, Nicholas http://orcid.org/0000-0002-7525-0384
Ross, Catherine
Brown, Kevin R. http://orcid.org/0000-0002-5514-2538
Zid, Abdelrahman Abou
Fan, Zi Peng
Hui, Shirley
Krall, Jordan A.
Simons, Donald M.
Slater, Chloe J.
De Jesus, Victor
Tang, Lujia
Singh, Richa
Goldford, Joshua E.
Martin, Sarah
Huang, Qian
Francis, Elizabeth A.
Habsid, Andrea
Climie, Ryan
Tieu, David
Wei, Jiarun
Li, Ren
Tong, Amy Hin Yan
Aregger, Michael http://orcid.org/0000-0001-6443-9870
Chan, Katherine S.
Han, Hong
Wang, Xiaowei
Mero, Patricia
Brumell, John H. http://orcid.org/0000-0002-5802-7789
Finelli, Antonio
Ailles, Laurie http://orcid.org/0000-0001-7289-8882
Bader, Gary http://orcid.org/0000-0003-0185-8861
Smolen, Gromoslaw A. http://orcid.org/0000-0003-0136-4685
Kingsbury, Gillian A.
Hart, Traver
Kung, Charles
Moffat, Jason http://orcid.org/0000-0002-5663-8586
Article History
Received: 9 September 2019
Accepted: 30 June 2020
First Online: 23 September 2020
Competing interests
: C.M.S., Z.P.F., J.A.K., S.M., D.M.S., C.J.S., V.D.J., L.T., R.S., J.E.G., G.A.S., G.A.K. and C.K. are employees of and have ownership interest in Agios Pharmaceuticals. This project was funded in part through a sponsored research agreement awarded to J.M. from Agios Pharmaceuticals. J.M. is a shareholder in Northern Biologics and Pionyr Immunotherapeutics, and is an advisor and shareholder of Century Therapeutics and Aelian Biotechnology. A.F. has received honoraria from Amgen, Abbvie, Janssen, Astellas, Sanofi, Bayer and TerSera (advisory boards and invited speakers), and research funds through a sponsored research agreement with Celsius Therapeutics. The remaining authors declare no competing interests.